Skip to content
Junfeng Feng’s Lab

News / A Lancet Neurology commentary assesses real-world intracranial pressure monitoring

A Lancet Neurology commentary assesses real-world intracranial pressure monitoring

2021-06-18 · BrainMed Neurosurgery News

A Lancet Neurology commentary assesses real-world intracranial pressure monitoring
Original source image

On 16 June, The Lancet Neurology (impact factor 30.039) published “Real-world Assessment of the Value of Intracranial Pressure Monitoring,” a commentary by Jiyao Jiang and Junfeng Feng of the Renji Head Trauma Centre, Shanghai Jiao Tong University School of Medicine. It assessed the accompanying, internationally largest real-world ICP monitoring study, compared related studies, reviewed global practice and proposed research priorities.

On 30 April that year, Jiang, Renji Chief Expert and Director of the Shanghai Institute of Head Trauma, received an editorial invitation. Centre Director Dr Junfeng Feng drafted and repeatedly revised the commentary. Jiang is corresponding author and Feng first author. They regarded the large multicentre real-world study as a major contribution to global ICP monitoring, with potential benefits for patients with acute brain injury—TBI, intracerebral haemorrhage and subarachnoid haemorrhage—particularly TBI.

TBI is a serious global public health problem. China records hundreds of thousands of new cases annually, with great losses to families and society. Pathophysiological changes following TBI and other acute injuries may increase ICP. Malignant intracranial hypertension is a principal contributor to poor outcomes, making monitoring and treatment central to modern care. The fourth US Guidelines for the Management of Severe TBI and Chinese expert consensuses led by Renji describe direct, continuous measurement with an implanted probe as the most reliable current method of evaluating dynamic ICP changes.

Earlier large studies, however, had not conclusively demonstrated improved outcomes with ICP-guided care. The accompanying “Intracranial Pressure Monitoring in the Intensive Care Unit: An International Multicentre Prospective Observational Study” included 2,395 patients from 146 centres in 42 countries, with TBI, cerebral haemorrhage or subarachnoid haemorrhage. The source reports an association between monitoring and significantly lower death or disability and better neurological outcomes in severe injury. Jiang and Feng compared the depth of previous evidence and the breadth of international practice. They argued that understanding of monitoring’s value had entered a new phase deserving attention, advocated greater clinical application and emphasised comparative-effectiveness research and high-quality randomised trials as next steps.

Jiang noted that compared with a monitoring rate of 62% in severe injury in Europe and the US, China’s rate in severe TBI remained low. Standardised care concepts, pathways and surgical techniques, together with multimodal monitoring including ICP, require wider uptake to improve care.

Since 2019, Jiang’s team and national colleagues have published six Lancet Neurology articles covering clinical research, reviews, correspondence, commentary and editorial discussion. The Renji Head Trauma Centre was established as a new department in April 2021, directed by Dr Feng, with ten physicians at the time of this report. The team will continue contributing to Chinese TBI care. Preparations for the PORTALS-AEDH clinical study are complete, and a final round of centre recruitment has begun; colleagues are invited to participate in this real-world study of surgery for acute epidural haematoma.

Original paper: https://www.sciencedirect.com/science/article/abs/pii/S1474442221001642

Copyright notice: Intellectual property in content published by BrainMed’s Neurosurgery News, Neurointerventional News and Brain Medical Consultation belongs to BrainMed, the organisers, original authors and other rights holders. Republishing, excerpting, copying, cropping or recording without permission is prohibited. Authorised use must acknowledge the source. Forwarding and sharing are welcomed.

The original report also announced a new patient consultation room in the BrainMed app, formerly the Neurosurgery News / Neurointerventional News app, for answering patient questions during available time, with an invitation to try it through the original article link.

原文配图

6月16日,世界顶级医学杂志《柳叶刀神经病学》(《The Lancet Neurology》,影响因子30.039)正式发表上海交通大学医学院附属仁济医院颅脑创伤中心江基尧教授和冯军峰主任题为《颅内压监测价值的真实世界评估》的点评文章。对同期发表的国际上最大规模的一项颅内压监测的真实世界研究做了客观评论,并对多项相关研究做了比较分析,从全球视角做了总结,最后提出了重要的研究方向。

今年4月30日,上海交通大学医学院附属仁济医院首席专家、上海市颅脑创伤研究所所长江基尧教授收到《柳叶刀神经病学》编辑来信,邀请撰写点评文章。仁济医院颅脑创伤中心主任冯军峰博士执笔反复修改完成。江基尧教授为文章的通信作者,冯军峰主任为第一作者。文章对同期发表的目前最大规模的一项颅内压监测的多中心真实世界研究做了客观评价,认为该项研究是对全球颅内压监测应用的一个巨大推动,必将造福更广大的急性脑损伤患者(颅脑创伤、脑出血和蛛网膜下腔出血)、尤其是颅脑创伤患者。

颅脑创伤在世界范围内都是一个严峻的公共卫生问题,我国每年新增颅脑创伤患者数十万,给社会和家庭带来巨大损失。颅脑创伤、以及脑出血等急性脑损伤发生后,伴发的各种病理生理过程会导致颅内压力的增高。而恶性颅内压增高往往是导致患者不良预后的最主要因素,对其监测和治疗也就成为现代急性脑损伤救治及管理体系中的核心环节。包括美国的《重型颅脑创伤救治指南(第四版)》,以及仁济颅脑创伤团队牵头制定的国内多项专家共识,都指出通过植入颅内压探头来直接、连续地监测颅内压,是目前评估患者颅内压力动态变化的最可靠的手段。

但遗憾的是,之前的多项大规模临床研究未能充分证实颅内压监测指导下的救治能够带来更好的救治效果。6月16日在《柳叶刀神经病学》同期发表的《监护室内的颅内压监测:一项国际多中心、前瞻性、观察性研究》文章中,纳入了42个国家146家单位2395例急性脑损伤患者(颅脑创伤、脑出血和蛛网膜下腔出血)。研究发现对于重型脑损伤患者,颅内压监测的应用显著降低患者死残率、显著改善脑神经功能预后。仁济颅脑创伤中心江基尧教授和冯军峰主任为这项研究做了客观点评。从相关临床研究的纵向深度和目前不同国家研究现状的地理宽度上,做了分析和总结。特别指出,对于颅内压监测价值的认识从此开始进入一个新的层面,值得脑损伤救治领域专家的高度重视。在临床实践中,应更积极地推动其临床应用;而在后继临床研究中,要着重开展疗效比较研究、高质量的随机对照研究。

江基尧教授指出,与欧美国家对于重型脑损伤的颅内压监测率62%相比,我国相应的重型颅脑创伤颅内压监测率仍然很低。对于我国的颅脑创伤临床救治工作,仍需要大力推广规范化救治的理念、方案、乃至手术技术,积极推广颅内压在内的多模态脑监测技术,提升脑创伤患者救治水准,造福众多患者。

仁济医院颅脑创伤团队在江基尧教授的带领下,携手颅脑创伤全国专家,从2019年开始在《柳叶刀神经病学》杂志上相继发表了6篇文章,包括临床研究论著、综述、通信、专家点评、述评等,在国际舞台上展现了中国颅脑创伤学术水平。仁济医院颅脑创伤中心是2021年4月仁济医院最新成立的科室,冯军峰博士担任中心主任,目前团队10位医生。仁济颅脑创伤团队将继续努力,为推动我国颅脑创伤救治事业发展做出更大成绩。

PORTALS-AEDH临床研究各项准备都已经到位,启动最后一轮参研单位招募(点击查看详情),欢迎全国同道积极参与,共同开展急性硬膜外血肿手术的真实世界研究。

文章原文链接:https://www.sciencedirect.com/science/article/abs/pii/S1474442221001642


声明:脑医汇旗下神外资讯、神介资讯、脑医咨询所发表内容之知识产权为脑医汇及主办方、原作者等相关权利人所有。未经许可,禁止进行转载、摘编、复制、裁切、录制等。经许可授权使用,亦须注明来源。欢迎转发、分享。

脑医汇App(原神外资讯/神介资讯App)对患咨询室全新上线,碎片化时间解答患者咨询,点击下方“”抢先体验!

Scroll to Top